FDA warning letter · Drugs

Inhousepharmacy.vu

Issued May 4, 2022 · Posted by FDA May 10, 2022

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1
your website introduces into interstate commerce domperidone drug products that are unapproved new drugs in violation of sections 301(d) and 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) [21 U.S.C. §§331(d) and 355(a)].